Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy Study of AB002 (E-WE Thrombin) in End Stage Renal Disease Patients on Chronic Hemodialysis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03963895
Recruitment Status : Completed
First Posted : May 28, 2019
Last Update Posted : February 3, 2021
Sponsor:
Collaborator:
Celerion
Information provided by (Responsible Party):
Aronora, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 28, 2020
Actual Study Completion Date : December 28, 2020